Skip to content

Join The Lazy Contractor's Blueprint live on Nov 28 — show up and get $50 in free Mindy creditsJoin The Lazy Contractor's Blueprint, free and live on Nov 28

Register free
Home/Contractors/Phlow Corp./contracts

Federal Contractor Profile

Phlow Corp.

$703M obligated·4 awards·2 agencies·2 NAICS
OverviewContractsAgenciesNAICS

Federal Contracts

Showing award actions 1–14 of 14 funded award actions, most recent first.

Contracts with positive obligations
4
Funded award actions shown
14
Obligations shown
$703M
Awarding agencies
2

This table shows award actions with a positive obligation. Zero-dollar and negative-dollar actions, such as administrative changes and deobligations, are not displayed. Multiple award actions may belong to the same contract.

Award data as of August 24, 2026. Source: USAspending federal award records.

DateAgencyPIIDNAICSDescriptionAmount
Jan 26, 2026Department of Health and Human ServicesASPR/DAAPPO/ORM HQ75A50120C00092325412US BASED ADVANCED API MANUFACTURING. BASE PERIOD FUNDING FOR US BASED ADVANCED MANUFACTURING OF COVID-19 ESSENTIAL MEDICINES AND FUTURE THREATS.$26M
Jan 26, 2026Department of Health and Human ServicesASPR/DAAPPO/ORM HQ75A50120C00092325412US BASED ADVANCED API MANUFACTURING. BASE PERIOD FUNDING FOR US BASED ADVANCED MANUFACTURING OF COVID-19 ESSENTIAL MEDICINES AND FUTURE THREATS.$54M
Nov 4, 2025Department of Health and Human ServicesASPR/DAAPPO/ORM HQ75A50120C00092325412US BASED ADVANCED API MANUFACTURING. BASE PERIOD FUNDING FOR US BASED ADVANCED MANUFACTURING OF COVID-19 ESSENTIAL MEDICINES AND FUTURE THREATS.$25M
Sep 30, 2025Department of Health and Human ServicesASPR/DAAPPO/ORM HQ75A50120C00092325412US BASED ADVANCED API MANUFACTURING. BASE PERIOD FUNDING FOR US BASED ADVANCED MANUFACTURING OF COVID-19 ESSENTIAL MEDICINES AND FUTURE THREATS.$8.4M
Sep 30, 2024Department of Health and Human ServicesASPR/DAAPPO/ORM HQ75A50120C00092325412US BASED ADVANCED API MANUFACTURING. BASE PERIOD FUNDING FOR US BASED ADVANCED MANUFACTURING OF COVID-19 ESSENTIAL MEDICINES AND FUTURE THREATS.$7.1M
Sep 29, 2024Department of Health and Human ServicesASPR/DAAPPO/ORM HQ75A50120C00092325412US BASED ADVANCED API MANUFACTURING. BASE PERIOD FUNDING FOR US BASED ADVANCED MANUFACTURING OF COVID-19 ESSENTIAL MEDICINES AND FUTURE THREATS.$3.9M
Sep 18, 2024Department of Health and Human ServicesASPR/DAAPPO/ORM HQ75A50120C00092325412US BASED ADVANCED API MANUFACTURING. BASE PERIOD FUNDING FOR US BASED ADVANCED MANUFACTURING OF COVID-19 ESSENTIAL MEDICINES AND FUTURE THREATS.$52M
Sep 11, 2024Department of Health and Human ServicesASPR/DAAPPO/ORM HQ75A50120C00092325412US BASED ADVANCED API MANUFACTURING. BASE PERIOD FUNDING FOR US BASED ADVANCED MANUFACTURING OF COVID-19 ESSENTIAL MEDICINES AND FUTURE THREATS.$9.9M
Aug 28, 2024Department of Health and Human ServicesASPR/DAAPPO/ORM HQ75A50120C00092325412US BASED ADVANCED API MANUFACTURING. BASE PERIOD FUNDING FOR US BASED ADVANCED MANUFACTURING OF COVID-19 ESSENTIAL MEDICINES AND FUTURE THREATS.$7.7M
Jul 3, 2024Department of Health and Human ServicesASPR/DAAPPO/ORM HQ75A50120C00092325412US BASED ADVANCED API MANUFACTURING. BASE PERIOD FUNDING FOR US BASED ADVANCED MANUFACTURING OF COVID-19 ESSENTIAL MEDICINES AND FUTURE THREATS.$10M
Sep 26, 2023Department of Health and Human ServicesASPR/DAAPPO/ORM HQ75A50120C00092325412US BASED ADVANCED API MANUFACTURING. BASE PERIOD FUNDING FOR US BASED ADVANCED MANUFACTURING OF COVID-19 ESSENTIAL MEDICINES AND FUTURE THREATS.$51M
Dec 21, 2021Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA75A50120C00092325412US BASED ADVANCED API MANUFACTURING. BASE PERIOD FUNDING FOR US BASED ADVANCED MANUFACTURING OF COVID-19 ESSENTIAL MEDICINES AND FUTURE THREATS.$87M
May 18, 2020Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA75A50120C00092325412US BASED ADVANCED API MANUFACTURING. BASE PERIOD FUNDING FOR US BASED ADVANCED MANUFACTURING OF COVID-19 ESSENTIAL MEDICINES AND FUTURE THREATS.$354M
Apr 23, 2020Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA75A50120P00071424210COVID-19 ESSENTIAL API AND MEDICINES$6.0M

Get Alerted Before Phlow Corp.'s Next Recompete

Mindy monitors active contracts and flags recompetes 12 months out so you can position to compete.

Start for free